Skip to main content
$1.41 -0.07 (-4.42%) At close · Jul 24
Market Cap
$140.10M
Shares
100.07M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.47 Open$1.50 Day$1.44–1.52 52W$1.26–8.59 Avg vol 30d354K Short int413K · 0.4% float · 1.6d Short vol45% Last earningsSep 30, 2025 DataApr 2021–Jul 2026

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 18.6 · elevated Equity put/call 0.79
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −61%
below
Price vs 50-day avg −28%
below
RSI (14) 32
neutral
MACD trend Positive
52-week position 3%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −9%
trailing
6-month return −70%
trailing
YTD return −68%
this year
Relative strength −76%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow Accumulating
8 of 34 funds reported for Jun 30 · net +29.3K sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.41% of float · ▲ +38.3% MoM · 1.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
34 holders — near 3-yr high, broad support
Squeeze score 46
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 81%
annualized · 1-yr
Max drawdown −83%
past year
ATR 7.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−61% Bearish
Price vs 50-day avg
−28% Bearish
RSI (14)
32 Neutral
MACD trend
Positive Bullish
52-week position
3% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow Accumulating
8 of 34 funds reported for Jun 30 · net +29.3K sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.41% of float · ▲ +38.3% MoM · 1.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
34 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $1 Now $1 · 3% 52-wk high $9
vs 200-day avg -61% vs 50-day avg -28%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Instruments & Supplies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NYXH
Nyxoah SA
this stock
$140.10M -68.0% 0.4%
ISRG
Intuitive Surgical Inc
$119.23B -41.4% +20.5% 38.8 1.9%
MDLN
Medline Inc.
$50.91B -7.7% +11.5% 2.2%
BDX
Becton Dickinson & Co
$43.08B +1.6% +8.2% 59.4 3.8%
ALC
Alcon Inc
$33.12B -14.7% +10.5% 2.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
34
% held
3.6%
Reported
8 of 34
Top holder
Vestal Point Capital, LP
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Short Interest Rising
Shares short
412.8K
Days to cover
1.6d
Change
+114.3K sh
View
Short Volume
Short vol %
45%
As of
Jul 24, 2026
Short Total
View
Fails to Deliver
FTD shares
4.6K
Value
$7.6K
As of
Jun 30, 2026
View
Off-Exchange
Off-exchange %
47.8%
Week of
May 4, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Jul 9, 2026
This year
10
View
Earnings & Events
Earnings Calls
Last call
Sep 30, 2025
View
Investor Relations
Upcoming events
2
View

Performance

5D 20D 120D MTD YTD
NYXH -9.3% -9.3% -69.9% -13.0% -68.0%
SPY -1.7% +0.7% +6.4% -1.2% +8.3%
vs SPY -7.6% -9.9% -76.3% -11.9% -76.3%
Key facts CIK 1857190 CUSIP B6S7WD106 13F (30d) 8 filings 8 filers Visit website Investor relations